Journal article

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK

Anne E Cust, Mark Harland, Enes Makalic, Daniel Schmidt, James G Dowty, Joanne F Aitken, Chantelle Agha-Hamilton, Bruce K Armstrong, Jenny H Barrett, May Chan, Yu-Mei Chang, Joanne Gascoyne, Graham G Giles, Elizabeth A Holland, Richard F Kefford, Kairen Kukalizch, Johanna Lowery, Juliette A Randerson-Moor, Helen Schmid, Claire F Taylor Show all

Journal of Medical Genetics | B M J PUBLISHING GROUP | Published : 2011


Awarded by National Health and Medical Research Council of Australia (NHMRC)

Awarded by Cancer Councils New South Wales

Awarded by Victoria and Queensland

Awarded by US National Institutes of Health

Awarded by Victorian Cancer Agency

Awarded by Cancer Research UK

Awarded by National Institute of Health

Funding Acknowledgements

The Australian Melanoma Family Study received funding from the National Health and Medical Research Council of Australia (NHMRC) (project grants 107359, 211172, 566946 and Program Grant 402761 to GJM and RFK); project grants from the Cancer Councils New South Wales (77/00, 06/10), Victoria and Queensland (371); and the US National Institutes of Health (via R01 grant CA-83115-01A2 to the international Melanoma Genetics Consortium (GenoMEL)). AEC is the recipient of an NHMRC public health postdoctoral fellowship (520018) and received a Victorian Cancer Agency Early Career Seed Grant (ECSG07_010). BKA's research was supported by a University of Sydney Medical Foundation Program Grant and JLH is an Australia Fellow of the NHMRC. This research was funded in part by Cancer Research UK (C588/A4994, C588/A10589 C8216/A6129) and by the National Institute of Health (CA83115). UK study recruitment was facilitated by the UK National Cancer Research Network.